Author: Kate Travis

Biotech company agrees to pay $4 million to settle data falsification allegations

A biotech company whose CEO faced allegations of manipulating data in papers used in NIH grant applications will pay a settlement of $4 million to resolve those allegations, the Department of Justice announced January 6. 

The settlement is the latest installment in a series of allegations surrounding research by Leen Kawas, the former CEO of the company, Bothell, Wash.-based Athira Pharma. In October 2021, four months after placing cofounder and then-CEO Kawas on leave, an internal investigation found she falsified images in her doctoral dissertation and at least four research papers. 

But concerns had been raised about the images as early as 2016, and Athira failed to report them, the DOJ statement noted. Those papers “were referenced in several grant applications submitted to NIH, including in a grant that NIH funded in 2019,” the statement continued.

Continue reading Biotech company agrees to pay $4 million to settle data falsification allegations

Elsevier denies AI use in response to evolution journal board resignations

The publisher of the Journal of Human Evolution says it does not use artificial intelligence in its production process, contrary to a statement issued last month by the journal’s editorial board when all but one member of the group resigned. 

The statement, shared on X on December 26, noted the journal’s “joint Editors-in-Chief, all Emeritus Editors retired or active in the field, and all but one Associate Editor” were resigning because Elsevier, the journal’s publisher, “has steadily eroded the infrastructure essential to the success of the journal while simultaneously undermining the core principles and practices that have successfully guided the journal for the past 38 years.” Among the examples cited: 

Continue reading Elsevier denies AI use in response to evolution journal board resignations